GSK
FDA Grants Expanded Indication for GSK’s Arexvy
The FDA granted a new indication for GSK’s Arexvy adjuvanted respiratory syncytial virus vaccine to prevent ...
JUNE 13, 2024
Orphan Drug Tafenoquine Gets FDA Advisory Committee Nod for Approval
The FDA Antimicrobial Drugs Advisory Committee today voted to recommended approval of GSK's tafenoquine for the ...
JULY 12, 2018
FDA Approves New Indication for Nucala
The FDA expanded the approved use of Nucala to treat adults with eosinophilic granulomatosis with polyangiitis, a ...
DECEMBER 14, 2017
FDA Approves Shingrix Shingles Vaccine
Shingrix is a recombinant subunit vaccine given intramuscularly in two doses that combines an antigen, glycoprotein ...
OCTOBER 24, 2017
Load more